Literature DB >> 15470903

Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profiling.

Thibault Verjat1, Elisabeth Cerrato, Marcel Jacobs, Philippe Leissner, Bruno Mougin.   

Abstract

Nucleic acid sequence-based amplification (NASBA) is a sensitive isothermal transcription-based amplification method. We have developed real-time NASBA assays to detect mRNA coding for the estrogen receptor alpha (ESR1) and the progesterone receptor (PGR) in breast tumors by means of duplex reactions using cyclophilin B (PPIB) as the normalizing gene. Both the ESR1/PPIB and PGR/PPIB duplex NASBA assays are highly sensitive, specific, and reproducible. Quantification is determined using external standard calibration curves and the ratio between the number of target and housekeeping gene mRNA copies. Amplification of the target gene in the duplex NASBA assay was disrupted when this latter was mixed with a large amount of the housekeeping PPIB gene, suggesting that it is preferable for the normalizing gene chosen to have an expression level comparable to the target gene. Sensitivity and robustness of the duplex NASBA assays were assessed in breast cancer cell lines. Such a rapid and easy-to-use multiparametric duplex real-time NASBA assay could also advantageously be set up for other mRNA profiling applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470903     DOI: 10.2144/04373PF01

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Real-time nucleic acid sequence-based amplification assay for rapid detection and quantification of agr functionality in clinical Staphylococcus aureus isolates.

Authors:  Liang Chen; Bo Shopsin; Yanan Zhao; Davida Smyth; Gregory A Wasserman; Christina Fang; Lisa Liu; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

2.  Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

Authors:  Philippe Leissner; Thibault Verjat; Thomas Bachelot; Malick Paye; Alexander Krause; Alain Puisieux; Bruno Mougin
Journal:  BMC Cancer       Date:  2006-08-31       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.